Morningstar DBRS has proposed loosening its rating criteria for residential MBS, given the strong performance of loans originated after 2008.

Mortgages for medical doctors are usually retained in bank portfolios.

Investors are showing increased interest in securitizations of traditional home equity loans and home equity investments.

Despite some concerns tied to fraud and performance, investors are optimistic that issuance volume will increase this year.

Agency-eligible loans are frequently being delivered to non-agency MBS instead of the GSEs.

Pending proposals from the Fed would impact MBS market; Moody’s looks to rate securitizations of home equity loans.

Issuance of expanded-credit mortgage-backed securities declined during the fourth quarter of 2025, marking the first quarterly decline in issuance for the sector in two years. (Includes three data tables.)

Lower interest rates and potential policy changes are expected to help drive an increase in prepayment activity this year.

A change in how MBS deals are rated led to more than 1,000 upgrades for tranches of deals backed by HELs and seasoned mortgages.

Growing acceptance of DSCR loans is helping drive improved lending flexibility.